For years, medical group leaders have wrestled with a familiar problem — more demand than workforce. Practices stretched schedules, recruited aggressively, leaned on APPs and fought burnout to keep up. In some markets, that pendulum has now begun to swing the other way.

Reports from practice leaders across the country point to a noticeable softening in patient volume through the first half of 2026, touching primary care, women's health, GI-related anesthesia, office visits and surgical services. The trend isn't universal — and that's precisely why it's dangerous. Leaders who respond to every soft week with cuts risk damaging the access, referral and outreach infrastructure they'll need to recover. Leaders who assume everything will bounce back may carry costs they can't sustain.

Jumping to "how much do we cut?" skips an important question: "What kind of demand has changed?" Some softness is seasonal, driven by the Q1 deductible reset. Some is affordability-driven — KFF reports 36% of adults skipped or postponed needed care last year because of cost. Some demand is being redirected to Amazon One Medical, Hims & Hers, Ro, retail clinics and AI self-triage, often priced below a patient's copay. Some is blocked by Medicare Advantage prior authorization. And some is being clinically reshaped by GLP-1s, home diagnostics and better chronic-disease control.

The full MGMA analysis unpacks the 10 drivers behind softening volume, the six categories every leader should use to segment demand before reacting, and specialty-specific playbooks for primary care, nonsurgical and surgical specialties, women's care and multispecialty groups — plus a phased right-sizing sequence that protects access and referral capture before any provider reductions are considered.